SciDev.Net

Less than one-tenth of all population-based research into dementia has been directed towards the two-thirds or more of all people with dementia who live in developing parts of the world — thus, the name "10/66".

Part of the Alzheimer's Disease International Network, 10/66 is a group of researchers who encourage active collaboration between research groups in different developing countries and between developed and developing countries. The research projects have included pilot studies to establish a method for diagnosing dementia in populations with very little formal education; qualitative studies to understand the experience of people with dementia and their carers; intervention studies that investigate whether local community health workers can contribute to care by identifying people who need help; and population-based studies to quantify prevalence and incidence in developing countries.

The 10/66 Group is part of Alzheimer's Disease International and is coordinated through Prof. Martin Prince from the Institute of Psychiatry, King's College, London.

The centre is a WHO collaborating centre for research and training in the control of cardiovascular disease, and also prevention and rehabilitation for patients in the Eastern Mediterranean Region.

The centre strongly advocates evidence-based health policies as the only way to promote health. Its focus on prevention led to the Isfahan Health Heart Programme, a community programme to promote healthier lifestyles to prevent non-communicable diseases.

The principal aim of TWAS is to promote scientific capacity and sustainable development in the South through research as well as South–South and North–South collaborations. It was founded in 1983 by a group of Southern scientists, under the leadership of Nobel Laureate Abdus Salam, as an autonomous international organisation. Fellows are citizens of the South; associate fellows are citizens of the North who were born in the South or have made significant contributions to science in the South.

IARC's mission is to undertake research on the causes of human cancer, the mechanisms of carcinogenesis, and to develop scientific strategies for cancer control. It develops strategies at a theoretical level, however, and does not get involved in direct implementation nor contribute to the formulation of policies or legislation. The agency also does not on the whole contribute to research in to cancer treatments.

The agency publishes several key publications on epidemiology (especially of the disease in developing countries), pathology and genetics. To encourage research, the agency offers several fellowships, scholarships and training courses.